Cite
HARVARD Citation
Merseburger, A. et al. (2021). Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice. Journal of urology. 206 (2), pp. 240-251. [Online].